Skip to main content
. Author manuscript; available in PMC: 2019 Apr 12.
Published in final edited form as: ACS Infect Dis. 2019 Mar 13;5(4):484–492. doi: 10.1021/acsinfecdis.9b00002

Table 1.

IC50 values (in nM) for AgrC antagonism by selected phase-one n7OFF analogs in S. aureus groups-I−IVa. 95% confidence intervals (CI) in parentheses.

compound group-I group-II group-III group-IV
n7OFF 181 (154−213) 583 (468−725) 332 (280−395) 5938 (4221−8532)
n7OF(3fF) 30.6 (22.5–41.8) 445 (217–911) 222 (158–312) ~3500 (ND)b
n7OF(3ClF) 125 (90–173) 167 (118–237) 630 (364–1090) 2240 (1150–4460)
n7OChaF 439 (278–695) 627 (317–1238) 194 (148–255) 1250 (990–1580)
n7OCpaF 141 (107–185) 204 (169–246) 19.7 (14.8–26.3) 498 (414–598)
Bn-n7OFF 15.3 (12.4–19.0) 37.8 (29.8–47.9) 17.3 (14.1–21.2) 564 (435–731)
Et-n7OFF 129 (97.7–170) 197 (152–255) 531 (312–905) --c
iPr-n7OFF 45.8 (34.0–61.9) 97.1 (65.6–144) 316 (192–522) --c
Pr-n7OFF 57.9 (30.3–111) 103 (68–155) 203 (121–341) --c
iBu-n7OFF 56.0 (38.6–81.2) 40.7 (35.3–46.9) 55.3 (37.7–81.0) --c
Bu-n7OFF 34.7 (28.1–42.8) 72.3 (45.6–115) 78.1 (43.6–140) --c
pentyl-n7OFF 15.8 (13.5–18.4) 17.0 (14.7–19.6) 15.7 (11.8–21.0) --c
Ph-n7OFF 157 (123–201) 23.0 (15.6–34.1) 98.2 (75.0–129) --c
n7OF(4fF) 375 (204–689) 354 (253–497) 2140 (1080–4220) --c
a

Data for parent n7OFF included for comparison. See Methods section for details of strains and assays. Comprehensive assay data for all compounds tested are provided in Tables S2−S3.

b

The confidence interval was too wide to quantify accurately.

c

Minimal activity at concentrations up to 10 μM; IC50 not calculated.